FDA Orange Book · active-ingredient family
Nedocromil sodium
Nedocromil sodium is approved as 3 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ALOCRIL · NDA 021009
3
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · aerosol, metered, solution, solution/drops
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ALOCRILRLD | ALLERGAN | NDA 021009 | — | Dec 08, 1999 | |
| TILADE | SANOFI AVENTIS US | NDA 020750 | — | Oct 01, 1997 | |
| TILADE | KING PHARMS LLC | NDA 019660 | — | Dec 30, 1992 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NEDOCROMIL SODIUM | EPIC PHARMA LLC | ANDA 090638 | — | Aug 22, 2012 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Nedocromil sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

